The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research von Painter, Corrie A., Jain, Esha, Tomson, Brett N., Dunphy, Michael, Stoddard, Rachel E., Thomas, Beena S., Damon, Alyssa L., Shah, Shahrayz, Kim, Dewey, Gómez Tejeda Zañudo, Jorge, Hornick, Jason L., Chen, Yen-Lin, Merriam, Priscilla, Raut, Chandrajit P., Demetri, George D., Van Tine, Brian A., Lander, Eric S., Golub, Todd R., Wagle, Nikhil

Volltext

Facts and Hopes in Immunotherapy of Soft-Tissue Sarcomas von Martín-Broto, Javier, Moura, David S, Van Tine, Brian A

Volltext

Sorafenib for Advanced and Refractory Desmoid Tumors von Gounder, Mrinal M, Mahoney, Michelle R, Van Tine, Brian A, Ravi, Vinod, Attia, Steven, Deshpande, Hari A, Gupta, Abha A, Milhem, Mohammed M, Conry, Robert M, Movva, Sujana, Pishvaian, Michael J, Riedel, Richard F, Sabagh, Tarek, Tap, William D, Horvat, Natally, Basch, Ethan, Schwartz, Lawrence H, Maki, Robert G, Agaram, Narasimhan P, Lefkowitz, Robert A, Mazaheri, Yousef, Yamashita, Rikiya, Wright, John J, Dueck, Amylou C, Schwartz, Gary K

Volltext

Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial von Adkins, Douglas, Prof, Ley, Jessica, BS, Neupane, Prakash, MD, Worden, Francis, Prof, Sacco, Assuntina G, MD, Palka, Kevin, MD, Grilley-Olson, Juneko E, MD, Maggiore, Ronald, MD, Salama, Noha N, PhD, Trinkaus, Kathryn, PhD, Van Tine, Brian A, MD, Steuer, Conor E, MD, Saba, Nabil F, Prof, Oppelt, Peter, MD

Volltext

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial von Tap, William D, Dr, Jones, Robin L, MD, Van Tine, Brian A, MD, Chmielowski, Bartosz, MD, Elias, Anthony D, Prof, Adkins, Douglas, Prof, Agulnik, Mark, MD, Cooney, Matthew M, MD, Livingston, Michael B, MD, Pennock, Gregory, MD, Hameed, Meera R, MD, Shah, Gaurav D, MD, Qin, Amy, PhD, Shahir, Ashwin, MD, Cronier, Damien M, PhD, Ilaria, Robert, MD, Conti, Ilaria, MD, Cosaert, Jan, MD, Schwartz, Gary K, Prof

Volltext

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial von Tawbi, Hussein A, Burgess, Melissa, Bolejack, Vanessa, Van Tine, Brian A, Schuetze, Scott M, Hu, James, D'Angelo, Sandra, Attia, Steven, Riedel, Richard F, Priebat, Dennis A, Movva, Sujana, Davis, Lara E, Okuno, Scott H, Reed, Damon R, Crowley, John, Butterfield, Lisa H, Salazar, Ruth, Rodriguez-Canales, Jaime, Lazar, Alexander J, Wistuba, Ignacio I, Baker, Laurence H, Maki, Robert G, Reinke, Denise, Patel, Shreyaskumar

Volltext

Pathogenesis and Current Treatment of Osteosarcoma: Perspectives for Future Therapies von Rathore, Richa, Van Tine, Brian A

Volltext

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multice... von Demetri, George D, von Mehren, Margaret, Jones, Robin L, Hensley, Martee L, Schuetze, Scott M, Staddon, Arthur, Milhem, Mohammed, Elias, Anthony, Ganjoo, Kristen, Tawbi, Hussein, Van Tine, Brian A, Spira, Alexander, Dean, Andrew, Khokhar, Nushmia Z, Park, Youn Choi, Knoblauch, Roland E, Parekh, Trilok V, Maki, Robert G, Patel, Shreyaskumar R

Volltext

Relapsed Synovial Sarcoma: Treatment Options von Weiss, Mia C., Van Tine, Brian A.

Volltext

A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma pa... von Rosenbaum, Evan, Chugh, Rashmi, Ryan, Christopher W., Agulnik, Mark, Milhem, Mohammed M., George, Suzanne, Jones, Robin L., Chmielowski, Bartosz, Van Tine, Brian A., Tawbi, Hussein, Elias, Anthony D., Read, William L., Budd, G. Thomas, Qin, Li-Xuan, Rodler, Eve T., Hirman, Joe, Weiden, Paul, Bennett, Cathryn M., Livingston, Philip O., Ragupathi, Govind, Hansen, David, D'Angelo, Sandra P., Tap, William D., Schwartz, Gary K., Maki, Robert G., Carvajal, Richard D.

Volltext

Systemic Anti-Cancer Therapy in Synovial Sarcoma: A Systematic Review von Riedel, Richard F, Jones, Robin L, Italiano, Antoine, Bohac, Chet, Thompson, Juliette C, Mueller, Kerstin, Khan, Zaeem, Pollack, Seth M, Van Tine, Brian A

Volltext

Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial von Schwartz, Gary K, Prof, Tap, William D, MD, Qin, Li-Xuan, PhD, Livingston, Michael B, Prof, Undevia, Samir D, MD, Chmielowski, Bartosz, MD, Agulnik, Mark, MD, Schuetze, Scott M, MD, Reed, Damon R, MD, Okuno, Scott H, Prof, Ludwig, Joseph A, MD, Keedy, Vicki, MD, Rietschel, Petra, MD, Kraft, Andrew S, Prof, Adkins, Douglas, Prof, Van Tine, Brian A, MD, Brockstein, Bruce, MD, Yim, Vincent, BA, Bitas, Christiana, BA, Abdullah, Abdul, BA, Antonescu, Cristina R, Prof, Condy, Mercedes, RN, Dickson, Mark A, MD, Vasudeva, Shyamprasad Deraje, MA, Ho, Alan L, MD, Doyle, L Austin, Prof, Chen, Helen X, Prof, Maki, Robert G, Prof

Volltext

A Single-Arm Phase II Trial of Sitravatinib in Advanced Well-Differentiated/Dedifferentiated Liposarcoma von Ingham, Matthew, Lee, Shing, Van Tine, Brian A, Choy, Edwin, Oza, Jay, Doshi, Sahil, Ge, Liner, Oppelt, Peter, Cote, Gregory, Corgiat, Brian, Sender, Naomi, Sta Ana, Sarah, Panchalingam, Lavan, Petricoin, Emmanuel, Schwartz, Gary K

Volltext

A phase I trial of temsirolimus and erlotinib in patients with refractory solid tumors von Park, Haeseong, Williams, Kerry, Trikalinos, Nikolaos A., Larson, Sarah, Tan, Benjamin, Waqar, Saiama, Suresh, Rama, Morgensztern, Daniel, Van Tine, Brian A., Govindan, Ramaswamy, Luo, Jingqin, Lockhart, A. Craig, Wang-Gillam, Andrea

Volltext

Long‐term effects of crizotinib in ALK‐positive tumors (excluding NSCLC): A phase 1b open‐label study von Gambacorti‐Passerini, Carlo, Orlov, Sergey, Zhang, Li, Braiteh, Fadi, Huang, Huiqiang, Esaki, Taito, Horibe, Keizo, Ahn, Jin‐Seok, Beck, Joseph T., Edenfield, William Jeffrey, Shi, Yuankai, Taylor, Matthew, Tamura, Kenji, Van Tine, Brian A., Wu, Shang‐Ju, Paolini, Jolanda, Selaru, Paulina, Kim, Tae Min

Volltext

The Metastatic Spine Disease Multidisciplinary Working Group Algorithms von Wallace, Adam N., Robinson, Clifford G., Meyer, Jeffrey, Tran, Nam D., Gangi, Afshin, Callstrom, Matthew R., Chao, Samuel T., Van Tine, Brian A., Morris, Jonathan M., Bruel, Brian M., Long, Jeremiah, Timmerman, Robert D., Buchowski, Jacob M., Jennings, Jack W.

Volltext

Multi-platform profiling of over 2000 sarcomas: identification of biomarkers and novel therapeutic targets von Movva, Sujana, Wen, Wenhsiang, Chen, Wangjuh, Millis, Sherri Z, Gatalica, Zoran, Reddy, Sandeep, von Mehren, Margaret, Van Tine, Brian A

Volltext

Editorial: New therapeutics for soft tissue sarcomas von Weetall, Marla, Rance, Mark, Ingham, Matthew, Van Tine, Brian A.

Volltext

Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcoma von Gyurdieva, Alexandra, Zajic, Stefan, Chang, Ya-Fang, Houseman, E. Andres, Zhong, Shan, Kim, Jaegil, Nathenson, Michael, Faitg, Thomas, Woessner, Mary, Turner, David C., Hasan, Aisha N., Glod, John, Kaplan, Rosandra N., D’Angelo, Sandra P., Araujo, Dejka M., Chow, Warren A., Druta, Mihaela, Demetri, George D., Van Tine, Brian A., Grupp, Stephan A., Fine, Gregg D., Eleftheriadou, Ioanna

Volltext

The novel drug candidate S2/IAPinh improves survival in models of pancreatic and ovarian cancer von Hagi, Takaomi, Vangveravong, Suwanna, Takchi, Rony, Gong, Qingqing, Goedegebuure, S. Peter, Tiriac, Herve, Van Tine, Brian A., Powell, Matthew A., Hawkins, William G., Spitzer, Dirk

Volltext